Why AGAMREE®?
AGAMREE is approved to treat Duchenne muscular dystrophy (DMD) in patients as young as 2 years of age
Download an educational brochure to help answer any questions you may have about AGAMREE
About AGAMREE
AGAMREE was developed to uncouple the anti-inflammatory effects of corticosteroids commonly used in DMD from certain side effects
While the way AGAMREE works to treat DMD is not fully understood, it is thought that AGAMREE treats DMD through its strong anti-inflammatory action
Effectiveness in Clinical Studies
AGAMREE is clinically proven to improve muscle strength and function in boys living with DMD
Study 1 included 121 male patients with DMD (ages 4 to less than 7 years) who were randomly assigned to be treated with AGAMREE 6 mg/kg/day (n=30), AGAMREE 2 mg/kg/day (n=30), prednisone 0.75 mg/kg/day (n=31), or placebo/sugar pill (n=30) for 24 weeks. The primary measure of muscle strength and function was the Time to Stand Test (TTSTAND) speed.
Side Effects With AGAMREE in Clinical Studies
What are the most common side effects associated with AGAMREE?
In clinical studies in boys living with DMD, the most common side effects with AGAMREE treatment included facial puffiness or cushingoid features, psychiatric disorders, vomiting, weight gain, and vitamin D deficiency. These are not all the possible side effects of AGAMREE.
Call your healthcare provider for medical advice about side effects.
aIncludes the following adverse reactions that occurred more frequently in the AGAMREE group than in placebo: abnormal behavior, aggression, agitation, anxiety, irritability, mood altered, sleep disorder, and stereotypy.
* Includes the following adverse reactions that occurred more frequently in the AGAMREE group than in placebo: abnormal behavior, aggression, agitation, anxiety, irritability, mood altered, sleep disorder, and stereotypy.
Learn about getting started on AGAMREE, including dosing and administration
Catalyst Pathways® offers a range of free, personalized support and services